Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab
리툭시맙 치료 후 지속적인 감염에서 SARS-CoV-2의 바이러스 진화 및 면역학
Case Reports
[키워드] accelerated
accumulated
accumulation
Asymptomatic
clade
Clinical course
clinical implications
Community
Complete
Complete Remission
Ct-value
Culture
Deletion
deletions
demonstrated
described
facilitate
growth
hospitalised
Immunocompromised
Immunocompromised host
immunocompromised individual
immunocompromised individuals
Immunocompromised patient
Immunocompromised patients
immunologic response
immunosuppressive
immunosuppressive therapy
increase in
individuals
Infection prevention
lymphocyte
Lymphocyte count
lymphoma
measure
Mutation
N-terminal domain
Nasopharyngeal swab
Patient
persistence
persistent
persistent infection
positive
Prolonged
qPCR
remained
rituximab
RT-qPCR
SARS-CoV-2
SARS-CoV-2 genome
Spike protein
Spread
the SARS-CoV-2 genome
therapy
variants
variants of concern
variants of concern (VOC)
Viral
viral evolution
virus
VoC
WGS
whole genome
Whole genome sequencing
wildtype
[DOI] 10.3390/v14040752 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.3390/v14040752 PMC 바로가기 [Article Type] Case Reports